Accessing the influence of 99mTc-Sesta-MIBI-positive thyroid nodules on preoperative localisation studies in patients with primary hyperparathyroidism - Summary - MDSpire

Accessing the influence of 99mTc-Sesta-MIBI-positive thyroid nodules on preoperative localisation studies in patients with primary hyperparathyroidism

  • By

  • Lindsay Hargitai

  • Maria Schefner

  • Tatjana Traub-Weidinger

  • Alexander Haug

  • Melisa Arikan

  • Christian Scheuba

  • Philipp Riss

  • January 21, 2022

  • 0 min

Share

Objective:

To investigate the impact of benign and malignant MIBI-positive thyroid nodules on the sensitivity of preoperative localisation of hyperfunctioning parathyroids in patients with primary hyperparathyroidism (PHPT).

Key Findings:
  • 30.8% of patients were asymptomatic.
  • 64.0% of patients showed at least one thyroid nodule.
  • MIBI scintigraphy has a high accuracy of 97% but can yield false positives due to solid thyroid nodules.
  • Sensitivity of MIBI can be affected by the presence of thyroid nodules.
Interpretation:

The presence of MIBI-positive thyroid nodules may complicate the preoperative localisation of hyperfunctioning parathyroids, potentially leading to false positive results and impacting surgical outcomes.

Limitations:
  • The study may not account for all variables affecting MIBI sensitivity, including potential biases in retrospective studies.
  • Results may vary due to the retrospective nature of the analysis.
Conclusion:

MIBI-positive thyroid nodules can significantly influence the accuracy of preoperative localisation studies in PHPT patients, necessitating careful evaluation during surgical planning.

Original Source(s)

Related Content